Literature DB >> 8307061

Pure progressive autonomic failure: a clinicopathological study.

Y Terao1, K Takeda, M Sakuta, T Nemoto, T Takemura, M Kawai.   

Abstract

Two cases of pure progressive autonomic failure (PAF) are presented. A postmortem study of one case (case 2) showed a pathology resembling that of Parkinson's disease. Marked cell loss was noted in the substantia nigra, nucleus ceruleus, and intermediolateral column of the spinal cord, while cell loss in the sympathetic ganglion was not remarkable. This case may be an exceptionally rare case of late-onset PAF in which autonomic failure was mainly ascribed to preganglionic (and central) pathology, although autonomic function tests suggested postganglionic sympathetic disorder in both cases.

Entities:  

Mesh:

Year:  1993        PMID: 8307061     DOI: 10.1159/000116985

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  7 in total

1.  Progression and prognosis in pure autonomic failure (PAF): comparison with multiple system atrophy.

Authors:  N Mabuchi; M Hirayama; Y Koike; H Watanabe; H Ito; R Kobayashi; K Hamada; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

2.  Natural history of pure autonomic failure: A United States prospective cohort.

Authors:  Horacio Kaufmann; Lucy Norcliffe-Kaufmann; Jose-Alberto Palma; Italo Biaggioni; Phillip A Low; Wolfgang Singer; David S Goldstein; Amanda C Peltier; Cyndia A Shibao; Christopher H Gibbons; Roy Freeman; David Robertson
Journal:  Ann Neurol       Date:  2017-02       Impact factor: 10.422

3.  Orthostatic hypotension as an early finding in Parkinson's disease.

Authors:  David S Goldstein
Journal:  Clin Auton Res       Date:  2006-02       Impact factor: 4.435

4.  Alpha-Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure.

Authors:  Wolfgang Singer; Ann M Schmeichel; Mohammad Shahnawaz; James D Schmelzer; David M Sletten; Tonette L Gehrking; Jade A Gehrking; Anita D Olson; Mariana D Suarez; Pinaki P Misra; Claudio Soto; Phillip A Low
Journal:  Ann Neurol       Date:  2021-04-30       Impact factor: 11.274

5.  Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies.

Authors:  David S Goldstein; Patti Sullivan; Courtney Holmes; Guillaume Lamotte; Abhishek Lenka; Yehonatan Sharabi
Journal:  J Neurochem       Date:  2021-05-21       Impact factor: 5.546

6.  Autonomic ganglionic injection of α-synuclein fibrils as a model of pure autonomic failure α-synucleinopathy.

Authors:  Xue-Jing Wang; Ming-Ming Ma; Le-Bo Zhou; Xiao-Yi Jiang; Miao-Miao Hao; Robert K F Teng; Erxi Wu; Bei-Sha Tang; Jia-Yi Li; Jun-Fang Teng; Xue-Bing Ding
Journal:  Nat Commun       Date:  2020-02-18       Impact factor: 14.919

Review 7.  Brain-First versus Gut-First Parkinson's Disease: A Hypothesis.

Authors:  Per Borghammer; Nathalie Van Den Berge
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.